Source: International Immunopharmacology. Unidade: FMRP
Subjects: ANTI-INFLAMATÓRIOS, DIFERENCIAÇÃO CELULAR, CITOCINAS, GENÉTICA, MEDULA ESPINHAL, LINFÓCITOS T
ABNT
PRADO, Douglas Silva et al. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism. International Immunopharmacology, v. 91, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2020.107278. Acesso em: 01 maio 2024.APA
Prado, D. S., Damasceno, L. E. A., Sonego, A. B., Rosa, M. H., Martins, T. V., Fonseca, M. D. M., et al. (2021). Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism. International Immunopharmacology, 91. doi:10.1016/j.intimp.2020.107278NLM
Prado DS, Damasceno LEA, Sonego AB, Rosa MH, Martins TV, Fonseca MDM, Cunha TM, Cunha F de Q, Alves Filho JCF. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism [Internet]. International Immunopharmacology. 2021 ; 91[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/j.intimp.2020.107278Vancouver
Prado DS, Damasceno LEA, Sonego AB, Rosa MH, Martins TV, Fonseca MDM, Cunha TM, Cunha F de Q, Alves Filho JCF. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism [Internet]. International Immunopharmacology. 2021 ; 91[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/j.intimp.2020.107278